praseodymium has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CLARKE, WJ; MAHLUM, DD | 1 |
| Bakht, MK; Sadeghi, M | 1 |
| Ahmadi, SJ; Bakht, MK; Sadeghi, M; Sadjadi, SS; Tenreiro, C | 1 |
1 review(s) available for praseodymium and Benign Neoplasms
| Article | Year |
|---|---|
Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy.
Topics: Brachytherapy; Cyclotrons; Female; Gamma Rays; Humans; Lanthanoid Series Elements; Male; Microspheres; Neoplasms; Nuclear Medicine; Praseodymium; Prostatic Neoplasms; Radioisotopes; Radiometry | 2011 |
2 other study(ies) available for praseodymium and Benign Neoplasms
| Article | Year |
|---|---|
INFLUENCE OF INTERNAL EMITTERS ON CHEMICAL CARCINOGENESIS. HW-80500.
Topics: Carcinogenesis; Cerium Isotopes; Chelating Agents; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; Neoplasms, Radiation-Induced; p-Dimethylaminoazobenzene; Pharmacology; Plutonium; Praseodymium; Radiation; Radioisotopes; Rats; Research | 1964 |
Preparation of radioactive praseodymium oxide as a multifunctional agent in nuclear medicine: expanding the horizons of cancer therapy using nanosized neodymium oxide.
Topics: Humans; Nanostructures; Neodymium; Neoplasms; Neutrons; Nuclear Medicine; Oxides; Praseodymium; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Solubility; Temperature; Water | 2013 |